The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)
Abstract
CONTEXT: The Heart and Estrogen/progestin Replacement Study (HERS) was a randomized trial of estrogen plus progestin therapy after menopause. OBJECTIVE: To examine the effect of long-term postmenopausal hormone therapy on common noncardiovascular disease outcomes. DESIGN AND SETTING: Randomized, blinded, placebo-controlled trial of 4.1 years' duration (HERS) and subsequent open-label observational follow-up for 2.7 years (HERS II), carried out between 1993 and 2000 in outpatient and community settings at 20 US clinical centers. PARTICIPANTS: A total of 2763 postmenopausal women with coronary disease and average age of 67 years at enrollment in HERS; 2321 women (93% of those surviving) consented to follow-up in HERS II. INTERVENTION: Participants were randomly assigned to receive 0.625 mg/d of conjugated estrogens plus 2.5 mg of medroxyprogesterone acetate (n = 1380) or placebo (n = 1383) during HERS; open-label hormone therapy was prescribed at personal physicians' discretion during HERS II. The proportions with at least 80% adherence to hormones declined from 81% (year 1) to 45% (year 6) in the hormone group and increased from 0% (year 1) to 8% (year 6) in the placebo group. MAIN OUTCOME MEASURES: Thromboembolic events, biliary tract surgery, cancer, fracture, and total mortality. RESULTS: Comparing women assigned to hormone therapy with those assigned to placebo, the unadjusted intention-to-treat relative hazard (RH) for venous thromboembolism declined from 2.66 (95% confidence interval [CI], 1.41-5.04) during HERS to 1.40 (95% CI, 0.64-3.05) during HERS II (P for time trend =.08); it was 2.08 overall for the 6.8 years (95% CI, 1.28-3.40), and 3 of the 73 women with thromboembolism died within 30 days due to pulmonary embolism. The overall RH for biliary tract surgery was 1.48 (95% CI, 1.12-1.95); for any cancer, 1.19 (95% CI, 0.95-1.50); and for any fracture, 1.04 (95% CI, 0.87-1.25). There were 261 deaths among those assigned to hormone therapy and 239 among those assigned to placebo (RH, 1.10; 95% CI, 0.92-1.31). Adjusted and as-treated analyses did not alter our conclusions. CONCLUSIONS: Treatment for 6.8 years with estrogen plus progestin in older women with coronary disease increased the rates of venous thromboembolism and biliary tract surgery. Trends in other disease outcomes were not favorable and should be assessed in larger trials and in broader populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D., Ettinger, B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,336
Self-citationEffect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Self-citationFifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Self-citationBush, T. L., Barrett-Connor, E., Cowan, L. D., Criqui, M. H., Wallace, R. B., Suchindran, C. M., Tyroler, H. A., & Rifkind, B. M. (1987) · Circulation · doi:10.1161/01.cir.75.6.1102 · Cited by 1,346
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Self-citationPostmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,184
Estrogen and the Risk of Breast Cancer
Clemons, M., & Goss, P. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440407 · Cited by 1,096
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
GRADY, D., GEBRETSADIK, T., KERLIKOWSKE, K., ERNSTER, V, & PETITTI, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 962
Self-citationA Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Risk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819
Estrogen Replacement Therapy and Fractures in Older Women
Cauley, J. A., Seeley, D. G., Ensrud, K., Ettinger, B., Black, D., Cummings, S. R., & and For The Study of Osteoporotic Fractures Research Group* (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00002 · Cited by 809
A prospective study of the incidence of deep‐vein thrombosis within a defined urban population
NORDSTRÖM, M., LINDBLAD, B., BERGQVIST, D., & KJELLSTRÖM, T. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00565.x · Cited by 777
Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., & for the Heart and Estrogen/progestin Replacement Study Research Group (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00002 · Cited by 715
Self-citationJick, H., Derby, L. E., Myers, M. W., Vasilakis, C., & Newton, K. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07114-0 · Cited by 602
Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis
Grodstein, F., Newcomb, P. A., & Stampfer, M. J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00063-7 · Cited by 584
Oral Contraceptives and the Risk of Venous Thrombosis
Vandenbroucke, J. P., Rosing, J., Bloemenkamp, K. W. M., Middeldorp, S., Helmerhorst, F. M., Bouma, B. N., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442007 · Cited by 579
Prospective study of exogenous hormones and risk of pulmonary embolism in women
Grodstein, F., Stampfer, M. J., Goldhaber, S. Z., Manson, J. E., Colditz, G. A., Speizer, F. E., Willett, W. C., & Hennekens, C. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07308-4 · Cited by 571
Torgerson, D. J., & Bell-Syer, S. E. M. (2001) · JAMA · doi:10.1001/jama.285.22.2891 · Cited by 522
Prior to Use of Estrogen Replacement Therapy, Are Users Healthier than Nonusers?
Matthews, K. A., Kuller, L. H., Wing, R. R., Meilahn, E. N., & Plantinga, P. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008678 · Cited by 517
Mosca, L., Collins, P., Herrington, D. M., Mendelsohn, M. E., Pasternak, R. C., Robertson, R. M., Schenck-Gustafsson, K., Smith, Jr., Taubert, K. A., & Wenger, N. K. (2001) · Circulation · doi:10.1161/hc2901.092200 · Cited by 438
Self-citationSimon, J. A., Hsia, J., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E., & Hulley, S. B. (2001) · Circulation · doi:10.1161/01.cir.103.5.638 · Cited by 403
Self-citationPostmenopausal Estrogen and Prevention Bias
Barrett-Connor, E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-455 · Cited by 376
Rabinowitz, H. K. (2001) · JAMA · doi:10.1001/jama.286.9.1041 · Cited by 350
Hulley, S., Furberg, C., & Barrett-Connor, E. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00920-0 · Cited by 339
Self-citationHormone replacement therapy and risk of venous thromboembolism: population based case-control study
Gutthann, S. P., Rodriguez, L. A. G., Castellsague, J., & Oliart, A. D. (1997) · BMJ · doi:10.1136/bmj.314.7083.796 · Cited by 338
Greendale, G. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00305-6 · Cited by 317
Pedersen, T. R., Wilhelmsen, L., Færgeman, O., Strandberg, T. E., Thorgeirsson, G., Troedsson, L., Kristianson, J., Berg, K., Cook, T. J., Haghfelt, T., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00910-3 · Cited by 274
Heart and Estrogen/progestin Replacement Study (HERS)
Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., & Hulley, S. B. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00010-5 · Cited by 260
Self-citationPathogenesis and Treatment of Gallstones
Johnston, D. E., & Kaplan, M. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302113280608 · Cited by 260
Which Medical Schools Produce Rural Physicians?
Rosenblatt, R. A. (1992) · JAMA · doi:10.1001/jama.1992.03490120073031 · Cited by 204
Psaty, B. M. (2001) · JAMA · doi:10.1001/jama.285.7.906 · Cited by 169
Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review
MacLennan, A., Lester, S., & Moore, V. (2001) · Climacteric · doi:10.1080/cmt.4.1.58.74 · Cited by 169
Women and lung cancer: does oestrogen play a role?
Siegfried, J. M. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00457-0 · Cited by 161
Alexander, K. P., Newby, L. K., Hellkamp, A. S., Harrington, R. A., Peterson, E. D., Kopecky, S., Langer, A., O’Gara, P. T., O’Connor, C. M., Daly, R. N., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01329-8 · Cited by 141
Self-citationCauley, J. A., Black, D. M., Barrett-Connor, E. L., Harris, F., Shields, K. M., Applegate, W. B., & Cummings, S. R. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00647-7 · Cited by 128
Preparing and retaining rural physicians through medical education
Pathman, D. E., Steiner, B., Jones, B. D., & Konrad, T. R. (1999) · Academic Medicine · doi:10.1097/00001888-199907000-00016 · Cited by 124
Grady, D. G., Herrington, D. M., Bittner, V., Blumenthal, R. S., Davidson, M. H., Hlatky, M. A., Hsia, J. A., Hulley, S. B., Herd, A. J., Khan, S. S., et al. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200210000-00020 · Cited by 124
Self-citationHulley, S. B., Furberg, C. D., Barrett-Connor, E. L., Cauley, J. A., Grady, D. G., Haskell, W. L., Knopp, R. H., Lowery, M. H., Satterfield, S., Schrott, H. G., et al. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200210000-00021 · Cited by 121
Self-citationPetitti, D. B. (1994) · Annals of Epidemiology · doi:10.1016/1047-2797(94)90056-6 · Cited by 106
Simon, J. A., Hunninghake, D. B., Agarwal, S. K., Lin, F., Cauley, J. A., Ireland, C. C., & Pickar, J. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00008 · Cited by 98
Heckbert, S. R., Kaplan, R. C., Weiss, N. S., Psaty, B. M., Lin, D.-Y., Furberg, C. D., Starr, J. R., Anderson, G. D., & LaCroix, A. Z. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.14.1709 · Cited by 97
Venous Thromboembolic Events Associated With Hormone Replacement Therapy
Grady, D. G., Hulley, S. B., & Furberg, C. (1997) · JAMA · doi:10.1001/jama.1997.03550060053030 · Cited by 94
Self-citationHsia, J. A., Simon, J. A., Lin, F., Applegate, W. B., Vogt, M. T., Hunninghake, D. B., & Carr, M. (2000) · Circulation · doi:10.1161/01.cir.102.18.2228 · Cited by 92
Self-citationVillareal, D. T., Binder, E. F., Williams, D. B., Schechtman, K. B., Yarasheski, K. E., & Kohrt, W. M. (2001) · JAMA · doi:10.1001/jama.286.7.815 · Cited by 90
Current perspectives on oral contraceptive use
Burkman, R. T., Collins, J. A., SHULMAN, L. P., & Williams, J. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117416 · Cited by 80
Subgroup Interactions in the Heart and Estrogen/Progestin Replacement Study: Lessons Learned
Furberg, C. D., Vittinghoff, E., Davidson, M., Herrington, D. M., Simon, J. A., WENGER, N. K., & Hulley, S. B. (2002) · Circulation · doi:10.1161/hc0802.104280 · Cited by 74
Self-citationFamily practice residency programs and the graduation of rural family physicians.
Bowman, R. C., & Penrod, J. D. (1998) · PubMed · Cited by 71
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T., Rogers, W. J., et al. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200101000-00020 · Cited by 52
Self-citationPostmenopausal Hormone Therapy for Prevention of Fractures
Grady, D. G., & Cummings, S. R. (2001) · JAMA · doi:10.1001/jama.285.22.2909 · Cited by 48
Self-citationThe Incidence of Unrecognized Myocardial Infarction in Women with Coronary Heart Disease
Shlipak, M. G., Elmouchi, D., Herrington, D. M., Lin, F., Grady, D. G., & Hlatky, M. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-11-200106050-00010 · Cited by 46
Self-citationHormones To Prevent Coronary Disease in Women: When Are Observational Studies Adequate Evidence?
Grady, D. G., & Hulley, S. B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00016 · Cited by 44
Self-citationGenazzani, A. R. (2002) · Circulation · doi:10.1161/01.cir.0000012248.01291.cf · Cited by 29
Hormone Replacement Therapy Increases the Risk of Breast Cancera
Colditz, G. A. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48598.x · Cited by 21
Early risk of cardiovascular events after commencing hormone replacement therapy
Rossouw, J. E. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200108000-00001 · Cited by 18
Alexander, K. P., Newby, L. K., & Hellkemp, A. S. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00455-x · Cited by 13
Self-citation
Cited by
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Metadata
- Authors
- Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., Newby, L. K., Waters, D., Vittinghoff, E., Wenger, N., & for the HERS Research Group
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-07-03
- Volume
- 288
- Issue
- 1
- Pages
- 49
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2113259481
- Cited by
- 1,930
- References
- 61
- FWCI
- 127.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.